GRIN2D Antikörper
Kurzübersicht für GRIN2D Antikörper (ABIN7228786)
Target
Alle GRIN2D Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- Rabbit Anti-GRIN2D Polyclonal Antibody
-
Spezifität
- This antibody detects endogenous levels of GRIN2D.
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from part region of human GRIN2D protein
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000,ELISA 1:10000-20000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- GRIN2D (Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2D (GRIN2D))
-
Andere Bezeichnung
- GRIN2D
-
Hintergrund
- Glutamate [NMDA] receptor subunit epsilon-4, EB11, N-methyl D-aspartate receptor subtype 2D, NMDAR2D, NR2DGRIN2D (Glutamate Ionotropic Receptor NMDA Type Subunit 2D) is a Protein Coding gene. Diseases associated with GRIN2D include Epileptic Encephalopathy, Early Infantile, 46 and Undetermined Early-Onset Epileptic Encephalopathy. Among its related pathways are Calcium signaling pathway and RET signaling.
-
Molekulargewicht
- 145kD
-
Gen-ID
- 2906
-
UniProt
- O15399
-
Pathways
- Synaptic Membrane
Target
-